1. Waksman R. late thrombosis after radiation. Sitting on a time bomb. Circulation 1999;100(8):780-2.
2. darby S, Mcgale P, Peto R, granath F, hall P, ekbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. Bmj 2003;326(7383):256-7.
3. Smith gl, Smith Bd, Buchholz TA et al. Cerebrovascular disease Risk in Older head and Neck Cancer Patients After Radiotherapy. J Clin Oncol 2008.
4. yeh eT, Tong AT, lenihan dJ et al. Cardiovascular complications of cancer therapy: diagnosis, pathogen-esis, and management. Circulation 2004;109(25):3122-31.
5. Altena R, Perik PJ, van Veldhuisen dJ, de Vries eg, gietema JA. Cardiovascular toxicity caused by cancer treatment: strategies for early detection. lancet Oncol 2009;10(4):391-9.
6. Pober JS, Sessa WC. evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007;7(10):803-15.
7. Cotran RS KV, Collins T, Robbins Sl. Robbins Pathologic Basis of disease. 8´th ed: W.B. Saunders Com-pany; 1999.
8. Winsauer g, de Martin R. Resolution of inflammation: intracellular feedback loops in the endothelium.
Thromb haemost 2007;97(3):364-9.
9. hansson gK. Inflammatory mechanisms in atherosclerosis. J Thromb haemost 2009;7 Suppl 1:328-31.
10. Basavaraju SR, easterly Ce. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002;29(10):2391-403.
11. Adams MJ, lipshultz Se, Schwartz C, Fajardo lF, Coen V, Constine lS. Radiation-associated cardiovascu-lar disease: manifestations and management. Semin Radiat Oncol 2003;13(3):346-56.
12. hoving S, heeneman S, gijbels MJ et al. Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in Apoe(-/-) mice. Int J Radiat Oncol Biol Phys 2008;71(3):848-57.
13. laberge MA, Moore KJ, Freeman MW. Atherosclerosis and innate immune signaling. Ann Med 2005;37(2):130-40.
14. Binder CJ, Chang MK, Shaw PX et al. Innate and acquired immunity in atherogenesis. Nat Med 2002;8(11):1218-26.
15. hansson gK, libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006;6(7):508-19.
16. Janeway CA, Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
17. Sen R, Baltimore d. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a post-translational mechanism. Cell 1986;47(6):921-8.
18. ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109 Suppl:S81-96.
19. hayden MS, ghosh S. Signaling to NF-kappaB. genes dev 2004;18(18):2195-224.
20. Bonizzi g, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immu-nity. Trends Immunol 2004;25(6):280-8.
21. gloire g, legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later.
Biochem Pharmacol 2006;72(11):1493-505.
22. huang TT, Wuerzberger-davis SM, Seufzer BJ et al. NF-kappaB activation by camptothecin. A linkage between nuclear dNA damage and cytoplasmic signaling events. J Biol Chem 2000;275(13):9501-9.
23. de Martin R, hoeth M, hofer-Warbinek R, Schmid JA. The transcription factor NF-kappa B and the regula-tion of vascular cell funcregula-tion. Arterioscler Thromb Vasc Biol 2000;20(11):e83-8.
24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362(6423):801-9.
25. Collins T, Read MA, Neish AS, Whitley MZ, Thanos d, Maniatis T. Transcriptional regulation of endothe-lial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. Faseb J 1995;9(10):899-909.
26. Iademarco MF, McQuillan JJ, dean dC. Vascular cell adhesion molecule 1: contrasting transcriptional con-trol mechanisms in muscle and endothelium. Proc Natl Acad Sci u S A 1993;90(9):3943-7.
27. Caldenhoven e, Coffer P, yuan J et al. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response ele-ment. J Biol Chem 1994;269(33):21146-54.
28. Read MA, Whitley MZ, gupta S et al. Tumor necrosis factor alpha-induced e-selectin expression is ac-tivated by the nuclear factor-kappaB and c-JuN N-terminal kinase/p38 mitogen-acac-tivated protein kinase pathways. J Biol Chem 1997;272(5):2753-61.
29. Xanthoulea S, Curfs dM, hofker Mh, de Winther MP. Nuclear factor kappa B signaling in macrophage function and atherogenesis. Curr Opin lipidol 2005;16(5):536-42.
30. Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001;107(3):255-64.
31. Trivedi CM, Patel RC, Patel CV. differential regulation of hOXA9 expression by nuclear factor kappa B (NF-kappaB) and hOXA9. gene 2008;408(1-2):187-95.
32. landry dB, Couper ll, Bryant SR, lindner V. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 1997;151(4):1085-95.
33. Raines eW, garton KJ, Ferri N. Beyond the endothelium: NF-kappaB regulation of smooth muscle function.
Circ Res 2004;94(6):706-8.
34. Bond M, Chase AJ, Baker Ah, Newby AC. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 2001;50(3):556-65.
35. Jovinge S, hultgardh-Nilsson A, Regnstrom J, Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 1997;17(3):490-7.
36. Ignarro lJ. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci Rep 1999;19(2):51-71.
37. Barbato Je, Tzeng e. Nitric oxide and arterial disease. J Vasc Surg 2004;40(1):187-93.
38. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro lJ. Nitric oxide and atherosclerosis:
an update. Nitric Oxide 2006;15(4):265-79.
39. Napoli C, Ignarro lJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 2009;32(8):1103-8.
40. liu VW, huang Pl. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res 2008;77(1):19-29.
41. Xie QW, Cho hJ, Calaycay J et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256(5054):225-8.
42. geng y, hansson gK, holme e. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992;71(5):1268-76.
43. eberhardt W, Kunz d, hummel R, Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide syn-thase gene promoter. Biochem Biophys Res Commun 1996;223(3):752-6.
44. hansson gK, geng yJ, holm J, hardhammar P, Wennmalm A, Jennische e. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J exp Med 1994;180(2):733-8.
45. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos h, Fang FC. Antimicrobial actions of the NAdPh phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. effects on microbial killing by activated peritoneal macrophages in vitro. J exp Med 2000;192(2):227-36.
46. hierholzer C, harbrecht B, Menezes JM et al. essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J exp Med 1998;187(6):917-28.
47. Andrew PJ, Mayer B. enzymatic function of nitric oxide synthases. Cardiovasc Res 1999;43(3):521-31.
48. Napoli C, Ignarro lJ. Nitric oxide and atherosclerosis. Nitric Oxide 2001;5(2):88-97.
49. doughan AK, harrison dg, dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochon-drial dysfunction: linking mitochonmitochon-drial oxidative damage and vascular endothelial dysfunction. Circ Res 2008;102(4):488-96.
50. lavi S, yang eh, Prasad A et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. hypertension 2008;51(1):127-33.
51. Schiffrin el. Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance under-lies endothelial dysfunction in the human coronary circulation. hypertension 2008;51(1):31-2.
52. esmon CT. Crosstalk between inflammation and thrombosis. Maturitas 2008;61(1-2):122-31.
53. Kruithof eK. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory media-tors and statins. Thromb haemost 2008;100(6):969-75.
54. landmesser u, hornig B, drexler h. endothelial function: a critical determinant in atherosclerosis? Circula-tion 2004;109(21 Suppl 1):II27-33.
55. Stone hB, Coleman CN, Anscher MS, McBride Wh. effects of radiation on normal tissue: consequences and mechanisms. lancet Oncol 2003;4(9):529-36.
56. dorresteijn ld, Kappelle AC, Scholz NM et al. Increased carotid wall thickening after radiotherapy on the neck. eur J Cancer 2005;41(7):1026-30.
57. ullrich NJ, Robertson R, Kinnamon dd et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007;68(12):932-8.
58. Baerlocher MO, Rajan dK, Ing dJ, Rubin BB. Primary stenting of bilateral radiation-induced external iliac stenoses. J Vasc Surg 2004;40(5):1028-31.
59. Sugihara T, hattori y, yamamoto y et al. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation. Circulation 1999;100(6):635-41.
60. Beckman JA, Thakore A, Kalinowski Bh, harris JR, Creager MA. Radiation therapy impairs endothelium-dependent vasodilation in humans. J Am Coll Cardiol 2001;37(3):761-5.
61. Russell NS, hoving S, heeneman S et al. Novel insights into pathological changes in muscular arteries of radiotherapy patients. Radiother Oncol 2009;92(3):477-83.
62. Robbins Me, Zhao W. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 2004;80(4):251-9.
63. Victor VM, Rocha M, Sola e, Banuls C, garcia-Malpartida K, hernandez-Mijares A. Oxidative stress, en-dothelial dysfunction and atherosclerosis. Curr Pharm des 2009;15(26):2988-3002.
64. Pepine CJ. The impact of nitric oxide in cardiovascular medicine: untapped potential utility. Am J Med 2009;122(5 Suppl):S10-5.
65. Perry A, Schmidt Re. Cancer therapy-associated CNS neuropathology: an update and review of the litera-ture. Acta Neuropathol 2006;111(3):197-212.
66. Omura M, Aida N, Sekido K, Kakehi M, Matsubara S. large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;38(2):241-9.
67. Ferrero V, Ribichini F, Piessens M et al. Intracoronary beta-irradiation for the treatment of de novo lesions:
5-year clinical follow-up of the BetAce randomized trial. Am heart J 2007;153(3):398-402.
68. Waksman R, Bhargava B, Mintz gS et al. late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000;36(1):65-8.
69. Mulrooney dA, yeazel MW, Kawashima T et al. Cardiac outcomes in a cohort of adult survivors of child-hood and adolescent cancer: retrospective analysis of the Childchild-hood Cancer Survivor Study cohort. Bmj 2009;339:b4606.
70. gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin Oncol (R Coll Radiol) 2005;17(3):153-9.
71. Clarke M, Collins R, darby S et al. effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. lancet 2005;366(9503):2087-106.
72. hooning MJ, Botma A, Aleman BM et al. long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007;99(5):365-75.
73. Bowers dC, Mulne AF, Reisch JS et al. Nonperioperative strokes in children with central nervous system tumors. Cancer 2002;94(4):1094-101.
74. gurney Jg, Kadan-lottick NS, Packer RJ et al. endocrine and cardiovascular late effects among adult sur-vivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003;97(3):663-73.
75. Bowers dC, McNeil de, liu y et al. Stroke as a late treatment effect of hodgkin’s disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005;23(27):6508-15.
76. de Bruin Ml, dorresteijn ld, van’t Veer MB et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of hodgkin lymphoma. J Natl Cancer Inst 2009;101(13):928-37.
77. dorresteijn ld, Kappelle AC, Boogerd W et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 2002;20(1):282-8.
78. Bitzer M, Topka h. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995;26(1):131-6.
79. Brant-Zawadzki M, Anderson M, deArmond SJ, Conley FK, Jahnke RW. Radiation-induced large intracra-nial vessel occlusive vasculopathy. AJR Am J Roentgenol 1980;134(1):51-5.
80. Farrugia M, gowda KM, Cheatle TR, Ashok TP. Radiotherapy-related axillary artery occlusive disease: per-cutaneous transluminal angioplasty and stenting. Two case reports and review of the literature. Cardiovasc Intervent Radiol 2006;29(6):1144-7.
81. Zhou W, Bush Rl, lin Ph, lumsden AB. Radiation-associated venous stenosis: endovascular treatment options. J Vasc Surg 2004;40(1):179-82.
82. Parsons JT, Bova FJ, Mendenhall WM, Million RR, Fitzgerald CR. Response of the normal eye to high dose radiotherapy. Oncology (Williston Park) 1996;10(6):837-47; discussion 47-8, 51-2.
83. Archer dB, Amoaku WM, gardiner TA. Radiation retinopathy--clinical, histopathological, ultrastructural and experimental correlations. eye (lond) 1991;5 ( Pt 2):239-51.
84. hatoum OA, Otterson MF, Kopelman d et al. Radiation induces endothelial dysfunction in murine in-testinal arterioles via enhanced production of reactive oxygen species. Arterioscler Thromb Vasc Biol 2006;26(2):287-94.
85. Schultze-Mosgau S, Rodel F, Radespiel-Troger M, Worl J, grabenbauer gg, Neukam FW. Vasculariza-tion of the area between free grafts and irradiated graft beds in the neck in rats. Br J Oral Maxillofac Surg 2002;40(1):37-44.
86. Schultze-Mosgau S, grabenbauer gg, Radespiel-Troger M et al. Vascularization in the transition area be-tween free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region. head Neck 2002;24(1):42-51.
87. gaugler Mh, Squiban C, Claraz M et al. Characterization of the response of human bone marrow endothe-lial cells to in vitro irradiation. Br J haematol 1998;103(4):980-9.
88. gaugler Mh, Squiban C, Mouthon MA, gourmelon P, van der Meeren A. Irradiation enhances the support of haemopoietic cell transmigration, proliferation and differentiation by endothelial cells. Br J haematol 2001;113(4):940-50.
89. Fischer-dzoga K, dimitrievich gS, griem Ml. Radiosensitivity of vascular tissue. II. differential radiosen-sitivity of aortic cells in vitro. Radiat Res 1984;99(3):536-46.
90. van Kleef eM, te Poele JA, Oussoren yg et al. Increased expression of glomerular von Willebrand factor after irradiation of the mouse kidney. Radiat Res 1998;150(5):528-34.
91. Wang J, Zheng h, Ou X, Fink lM, hauer-Jensen M. deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am J Pathol 2002;160(6):2063-72.
92. Paris F, Fuks Z, Kang A et al. endothelial apoptosis as the primary lesion initiating intestinal radiation dam-age in mice. Science 2001;293(5528):293-7.
93. Molla M, gironella M, Miquel R et al. Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of ex-perimental radiation-induced intestinal inflammation. Int J Radiat Oncol Biol Phys 2003;57(1):264-73.
94. Panes J, Molla M, Casadevall M et al. Tepoxalin inhibits inflammation and microvascular dysfunction in-duced by abdominal irradiation in rats. Aliment Pharmacol Ther 2000;14(6):841-50.
95. Qi F, Sugihara T, hattori y, yamamoto y, Kanno M, Abe K. Functional and morphological damage of en-dothelium in rabbit ear artery following irradiation with cobalt60. Br J Pharmacol 1998;123(4):653-60.
96. Bonetti PO, lerman lO, lerman A. endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23(2):168-75.
97. Panes J, Anderson dC, Miyasaka M, granger dN. Role of leukocyte-endothelial cell adhesion in radiation-induced microvascular dysfunction in rats. gastroenterology 1995;108(6):1761-9.
98. hallahan d, Clark eT, Kuchibhotla J, gewertz Bl, Collins T. e-selectin gene induction by ionizing radiation is independent of cytokine induction. Biochem Biophys Res Commun 1995;217(3):784-95.
99. gaugler Mh, Squiban C, van der Meeren A, Bertho JM, Vandamme M, Mouthon MA. late and persistent up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. Int J Radiat Biol 1997;72(2):201-9.
100. Vereycken-holler V, Aigueperse J, gaugler Mh. Radiation effects on circulating and endothelial cell interac-tions studied by quantitative real-time videomicroscopy. Int J Radiat Biol 2002;78(10):923-30.
101. Quarmby S, Kumar P, Kumar S. Radiation-induced normal tissue injury: role of adhesion molecules in leukocyte-endothelial cell interactions. Int J Cancer 1999;82(3):385-95.
102. Salame My, Verheye S, Mulkey SP et al. The effect of endovascular irradiation on platelet recruitment at sites of balloon angioplasty in pig coronary arteries. Circulation 2000;101(10):1087-90.
103. deiner C, Shagdarsuren e, Schwimmbeck Pl et al. Nf-kappab and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation. Cardiovasc Res 2007;75(1):195-204.
104. denham JW, hauer-Jensen M, Peters lJ. Is it time for a new formalism to categorize normal tissue radiation injury? Int J Radiat Oncol Biol Phys 2001;50(5):1105-6.
105. Johansson S, Svensson h, denekamp J. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 2000;48(3):745-50.
106. denham JW, hauer-Jensen M. The radiotherapeutic injury--a complex ‘wound’. Radiother Oncol 2002;63(2):129-45.
107. Barcellos-hoff Mh. how do tissues respond to damage at the cellular level? The role of cytokines in irradi-ated tissues. Radiat Res 1998;150(5 Suppl):S109-20.
108. Vujaskovic Z, Anscher MS, Feng QF et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 2001;50(4):851-5.
109. Rodemann hP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 1995;35(2):83-90.
110. gilbert eS. Ionising radiation and cancer risks: what have we learned from epidemiology? Int J Radiat Biol 2009;85(6):467-82.
111. eck. Kvoprosu o pereviazke vorotnoi veni: predvaritelnoye soobschjenie (Concerning ligation of the vena porta: preliminary notification). Voen Med Zh 1877;130:1-2.
112. Seidenberg B, Rosenak SS, hurwitt eS, Som Ml. Immediate reconstruction of the cervical esophagus by a revascularized isolated jejunal segment. Ann Surg 1959;149(2):162-71.
113. Suarez el, Jacobson Jh, 2nd. Results of small artery endarterectomy-microsurgical technique. Surg Forum 1961;12:256-7.
114. daniel RK, Taylor gI. distant transfer of an island flap by microvascular anastomoses. A clinical technique.
Plast Reconstr Surg 1973;52(2):111-7.
115. Taylor gI, daniel RK. The free flap: composite tissue transfer by vascular anastomosis. Aust N Z J Surg 1973;43(1):1-3.
116. Bui dT, Cordeiro Pg, hu Qy, disa JJ, Pusic A, Mehrara BJ. Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 2007;119(7):2092-100.
117. Smit JM, Acosta R, Zeebregts CJ, liss Ag, Anniko M, hartman eh. early reintervention of compromised free flaps improves success rate. Microsurgery 2007;27(7):612-6.
118. Rozen WM, Chubb d, Whitaker IS, Acosta R. The efficacy of postoperative monitoring: A single surgeon comparison of clinical monitoring and the implantable doppler probe in 547 consecutive free flaps. Micro-surgery 2009.
119. Cheon yW, lee MC, Kim yS, Rah dK, lee WJ. gluteal artery perforator flap: a viable alternative for sacral radiation ulcer and osteoradionecrosis. J Plast Reconstr Aesthet Surg 2009.
120. Acland Rd, Flynn MB. Immediate reconstruction of oral cavity and oropharyngeal defects using microvas-cular free flaps. Am J Surg 1978;136(4):419-23.
121. Ostrup lT, Fredrickson JM. Reconstruction of mandibular defects after radiation, using a free, living bone graft transferred by microvascular anastomose. An experimental study. Plast Reconstr Surg 1975;55(5):563-72.
122. Baker SR, Krause CJ, Panje WR. Radiation effects on microvascular anastomosis. Arch Otolaryngol 1978;104(2):103-7.
123. Krag C, de Rose g, lyczakowski T, Freeman CR, Shapiro Sh. Free flaps and irradiated recipient vessels:
an experimental study in rabbits. Br J Plast Surg 1982;35(3):328-36.
124. Tan e, O’Brien BM, Brennen M. Free flap transfer in rabbits using irradiated recipient vessels. Br J Plast Surg 1978;31(2):121-3.
125. Bengtson BP, Schusterman MA, Baldwin BJ et al. Influence of prior radiotherapy on the development of postoperative complications and success of free tissue transfers in head and neck cancer reconstruction. Am J Surg 1993;166(4):326-30.
126. Kroll SS, Robb gl, Reece gP et al. does prior irradiation increase the risk of total or partial free-flap loss?
J Reconstr Microsurg 1998;14(4):263-8.
127. Schusterman MA, Miller MJ, Reece gP, Kroll SS, Marchi M, goepfert h. A single center’s experience with 308 free flaps for repair of head and neck cancer defects. Plast Reconstr Surg 1994;93(3):472-8; discussion 9-80.
128. hurvitz KA, Kobayashi M, evans gR. Current options in head and neck reconstruction. Plast Reconstr Surg 2006;118(5):122e-33e.
129. Moyer JS, Wolf gT, Bradford CR. Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol head Neck Surg 2004;12(2):82-7.
130. Scher Rl, esclamado RM. Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure. Semin Radiat Oncol 2009;19(1):17-23.
131. Wennerberg J. Pre versus post-operative radiotherapy of resectable squamous cell carcinoma of the head and neck. Acta Otolaryngol 1995;115(4):465-74.
132. Mathes SJ, Alexander J. Radiation injury. Surg Oncol Clin N Am 1996;5(4):809-24.
133. Ni Choileain N, Redmond hP. Cell response to surgery. Arch Surg 2006;141(11):1132-40.
134. ekstrom M, halle M, Bjessmo S, liska J, Kolak M, Fischer R, eriksson P, Tornvall P. Adipose tissue poten-tiates the inflammatory response to open heart surgery. In: 2nd european Congress of Immunology; 2009;
Berlin; 2009.
135. desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;85(1):109-17.
136. Baigrie RJ, lamont PM, Kwiatkowski d, dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg 1992;79(8):757-60.
137. Shenkin A, Fraser Wd, Series J et al. The serum interleukin 6 response to elective surgery. lymphokine Res 1989;8(2):123-7.
138. Szabo Z, Andersson Rg, Arnqvist hJ. Intraoperative muscle and fat metabolism in diabetic patients dur-ing coronary artery bypass graftdur-ing surgery: a parallel microdialysis and organ balance study. Br J Anaesth 2009;103(2):166-72.
139. Fellander g, Nordenstrom J, Tjader I, Bolinder J, Arner P. lipolysis during abdominal surgery. J Clin endo-crinol Metab 1994;78(1):150-5.
140. Wolfe RR, Martini WZ. Changes in intermediary metabolism in severe surgical illness. World J Surg 2000;24(6):639-47.
141. Thorne A, Aberg W, Carneheim C, Olivecrona T, Nordenstrom J. Influence of trauma on plasma elimination of exogenous fat and on lipoprotein lipase activity and mass. Clin Nutr 2005;24(1):66-74.
142. yamauchi J, Vollmar B, Wolf B, Menger Md. Role of TNF-alpha in local surgical trauma-induced micro-vascular dysfunction. dig Surg 1999;16(5):400-6.
143. Menger Md, Vollmar B. Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg 1996;83(5):588-601.
144. Seekamp A, Jochum M, Ziegler M, van griensven M, Martin M, Regel g. Cytokines and adhesion mol-ecules in elective and accidental trauma-related ischemia/reperfusion. J Trauma 1998;44(5):874-82.
145. Suganami T, yuan X, Shimoda y et al. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ Res 2009;105(1):25-32.
146. Kim F, Tysseling KA, Rice J et al. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol 2005;25(5):989-94.
147. Kleinert h, Wallerath T, euchenhofer C, Ihrig-Biedert I, li h, Forstermann u. estrogens increase transcrip-tion of the human endothelial NO synthase gene: analysis of the transcriptranscrip-tion factors involved. Hypertension 1998;31(2):582-8.
148. edgell CJ, Mcdonald CC, graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci u S A 1983;80(12):3734-7.
149. Irizarry RA, hobbs B, Collin F et al. exploration, normalization, and summaries of high density oligonucle-otide array probe level data. Biostatistics 2003;4(2):249-64.
150. Spector AA, hoak JC. An improved method for the addition of long-chain free fatty acid to protein solutions.
Anal Biochem 1969;32(2):297-302.
151. Azizzadeh B, Buga gM, Berke gS, larian B, Ignarro lJ, Blackwell Ke. Inhibitors of nitric oxide promote microvascular thrombosis. Arch Facial Plast Surg 2003;5(1):31-5.
152. Allen JF. Comment on the editorial ‘Back to darwin?’ in eMBO reports, November 2000. eMBO Rep 2001;2(2):76.
153. gannon F. Back to darwin? eMBO Rep 2000;5(1):373.
154. Criswell T, leskov K, Miyamoto S, luo g, Boothman dA. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 2003;22(37):5813-27.
155. Bu dX, erl W, de Martin R, hansson gK, yan ZQ. IKKbeta-dependent NF-kappaB pathway controls vas-cular inflammation and intimal hyperplasia. Faseb J 2005;19(10):1293-5.
156. little MP, gola A, Tzoulaki I. A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure. PloS Comput Biol 2009;5(10):e1000539.
157. gaugler Mh. A unifying system: does the vascular endothelium have a role to play in multi-organ failure following radiation exposure? Br J Radiol 2005;Supplement 27:100-5.
158. Westrick RJ, eitzman dT. Plasminogen activator inhibitor-1 in vascular thrombosis. Curr drug Targets 2007;8(9):966-1002.
159. Arnljots B, Wieslander JB, dougan P, Salemark l. Prevention of microvascular thrombosis with low-dose tissue plasminogen activator. Plast Reconstr Surg 1992;90(2):281-8.
160. Arnljots B, Wieslander JB, dougan P, Salemark l. Importance of fibrinolysis in limiting thrombus for-mation following severe microarterial trauma: an experimental study in the rabbit. Microsurgery 1991;12(5):332-9.
161. Steinberg hO, Tarshoby M, Monestel R et al. elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100(5):1230-9.
162. lundman P, Tornvall P, Nilsson l, Pernow J. A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis 2001;159(1):35-41.
163. Moers A, Schrezenmeir J. Palmitic acid but not stearic acid inhibits NO-production in endothelial cells. exp Clin endocrinol diabetes 1997;105 Suppl 2:78-80.
164. davda RK, Stepniakowski KT, lu g, ullian Me, goodfriend Tl, egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. hypertension 1995;26(5):764-70.
165. Cornwell dg, Panganamala RV. Atherosclerosis: an intracellular deficiency in essential fatty acids. Prog lipid Res 1981;20:365-76.
166. das uN. estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? Nutrition 2002;18(2):178-88.